Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: AbbVie | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: AbbVie

HUMIRA sales up 10% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie
2Q Revenues: $8.3 billion (+19%)
2Q Earnings: $2.0 billion (+4%)
YTD Revenues: $10.5 billion (+25%)
YTD Earnings: $4.8 billion (+31%)
Comments: HUMIRA sales increased 10% to $5.2 billion in the quarter. IMBRUVICA sales were $850 million, up 36%. Global HCV revenues were $973 million, up more than 100%. Creon sales were up 11% to $219 million. Lupron sales were $223 million, up 6%. Synthroid sales were flat at $193 million. AndroGel sales declined 17% to $128 million. Duodopa sales were $108 million, up 33%. Sevoflurane sales were up 8% to $113 million. Kaletra sales were down 18% to $91 million.
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters